Refinement of breast cancer classification by molecular characterization of histological special types
Weigelt, B, Horlings, HM, Kreike, B, Hayes, MM, Hauptmann, M, Wessels, LFA, de Jong, D, Van de Vijver, MJ, Veer, LJ Van't, Peterse, JL
Published in The Journal of pathology (01.10.2008)
Published in The Journal of pathology (01.10.2008)
Get full text
Journal Article
A specific gene expression signature for visceral organ metastasis in breast cancer
Savci-Heijink, C D, Halfwerk, H, Koster, J, Horlings, H M, van de Vijver, M J
Published in BMC cancer (08.04.2019)
Published in BMC cancer (08.04.2019)
Get full text
Journal Article
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
TURNER, N, LAMBROS, M. B, ASHWORTH, A, VAN DE VIJVER, M. J, REIS, J. S, HORLINGS, H. M, PEARSON, A, SHARPE, R, NATRAJAN, R, GEYER, F. C, VAN KOUWENHOVE, M, KREIKE, B, MACKAY, A
Published in Oncogene (08.04.2010)
Published in Oncogene (08.04.2010)
Get full text
Journal Article
BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer
Liefaard, M C, van der Voort, A, van Ramshorst, M S, Sanders, J, Vonk, S, Horlings, H M, Siesling, S, de Munck, L, van Leeuwen, A E, Kleijn, M, Mittempergher, L, Kuilman, M M, Glas, A M, Wesseling, J, Lips, E H, Sonke, G S
Published in Breast cancer research : BCR (19.06.2023)
Published in Breast cancer research : BCR (19.06.2023)
Get full text
Journal Article
Iatrogenic endometriosis harbors somatic cancer-driver mutations
Lac, V, Verhoef, L, Aguirre-Hernandez, R, Nazeran, T M, Tessier-Cloutier, B, Praetorius, T, Orr, N L, Noga, H, Lum, A, Khattra, J, Prentice, L M, Co, D, Köbel, M, Mijatovic, V, Lee, A F, Pasternak, J, Bleeker, M C, Krämer, B, Brucker, S Y, Kommoss, F, Kommoss, S, Horlings, H M, Yong, P J, Huntsman, D G, Anglesio, M S
Published in Human reproduction (Oxford) (01.01.2019)
Published in Human reproduction (Oxford) (01.01.2019)
Get full text
Journal Article
Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior
Savci-Heijink, C. D., Halfwerk, H., Hooijer, G. K. J., Koster, J., Horlings, H. M., Meijer, S. L., van de Vijver, M. J.
Published in Breast cancer research and treatment (01.04.2019)
Published in Breast cancer research and treatment (01.04.2019)
Get full text
Journal Article
High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma
Kraan, W, van Keimpema, M, Horlings, H M, Schilder-Tol, E J M, Oud, M E C M, Noorduyn, L A, Kluin, P M, Kersten, M J, Spaargaren, M, Pals, S T
Published in Leukemia (01.03.2014)
Published in Leukemia (01.03.2014)
Get full text
Journal Article
High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites
Kraan, W, Horlings, H M, van Keimpema, M, Schilder-Tol, E J M, Oud, M E C M, Scheepstra, C, Kluin, P M, Kersten, M J, Spaargaren, M, Pals, S T
Published in Blood cancer journal (New York) (06.09.2013)
Published in Blood cancer journal (New York) (06.09.2013)
Get full text
Journal Article
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade
Liefaard, M C, van der Voort, A, van Seijen, M, Thijssen, B, Sanders, J, Vonk, S, Mittempergher, L, Bhaskaran, R, de Munck, L, van Leeuwen-Stok, A E, Salgado, R, Horlings, H M, Lips, E H, Sonke, G S
Published in NPJ breast cancer (18.04.2024)
Published in NPJ breast cancer (18.04.2024)
Get full text
Journal Article
Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer
Nederlof, I, Hajizadeh, S, Sobhani, F, Raza, S E A, AbdulJabbar, K, Harkes, R, van de Vijver, M J, Salgado, R, Desmedt, C, Kok, M, Yuan, Y, Horlings, H M
Published in NPJ breast cancer (28.04.2022)
Published in NPJ breast cancer (28.04.2022)
Get full text
Journal Article
Cancer-Associated Mutations in Endometriosis without Cancer
Anglesio, Michael S, Papadopoulos, Nickolas, Ayhan, Ayse, Nazeran, Tayyebeh M, Noë, Michaël, Horlings, Hugo M, Lum, Amy, Jones, Siân, Senz, Janine, Seckin, Tamer, Ho, Julie, Wu, Ren-Chin, Lac, Vivian, Ogawa, Hiroshi, Tessier-Cloutier, Basile, Alhassan, Rami, Wang, Amy, Wang, Yuxuan, Cohen, Joshua D, Wong, Fontayne, Hasanovic, Adnan, Orr, Natasha, Zhang, Ming, Popoli, Maria, McMahon, Wyatt, Wood, Laura D, Mattox, Austin, Allaire, Catherine, Segars, James, Williams, Christina, Tomasetti, Cristian, Boyd, Niki, Kinzler, Kenneth W, Gilks, C. Blake, Diaz, Luis, Wang, Tian-Li, Vogelstein, Bert, Yong, Paul J, Huntsman, David G, Shih, Ie-Ming
Published in The New England journal of medicine (11.05.2017)
Published in The New England journal of medicine (11.05.2017)
Get full text
Journal Article
Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial
Geurts, V.C.M., Voorwerk, L., Balduzzi, S., Salgado, R., Van de Vijver, K., van Dongen, M.G.J., Kemper, I., Mandjes, I.A.M., Heuver, M., Sparreboom, W., Haanen, J.B.A.G., Sonke, G.S., Horlings, H.M., Kok, M.
Published in Breast (Edinburgh) (01.08.2023)
Published in Breast (Edinburgh) (01.08.2023)
Get full text
Journal Article
Left-sided native valve Staphylococcus aureus endocarditis
SLABBEKOORN, M, HORLINGS, H. M, VAN DER MEER, J. T. M, WINDHAUSEN, A, VAN DER SLOOT, J. A. P, LAGRAND, W. K
Published in Netherlands journal of medicine (01.11.2010)
Get full text
Published in Netherlands journal of medicine (01.11.2010)
Journal Article
P57 Value of circulating tumor DNA in the differentiation between malignant and benign ovarian tumors
Lof, P, Sistermans, EA, Wessels, L, Amant, F, van den Broek, D, Mom, CH, Hemelaar, M, van Baal, WM, Verbruggen, M, Rosier - van Dunné, F, Hermsen, B, Horlings, HM, Lok, CAR
Published in International journal of gynecological cancer (01.11.2019)
Published in International journal of gynecological cancer (01.11.2019)
Get full text
Journal Article
Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck
Persson, Marta, Andrén, Ywonne, Mark, Joachim, Horlings, Hugo M, Persson, Fredrik, Stenman, Göran
Published in Proceedings of the National Academy of Sciences - PNAS (03.11.2009)
Published in Proceedings of the National Academy of Sciences - PNAS (03.11.2009)
Get full text
Journal Article
A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer
Berns, Katrien, Horlings, Hugo M., Hennessy, Bryan T., Madiredjo, Mandy, Hijmans, E. Marielle, Beelen, Karin, Linn, Sabine C., Gonzalez-Angulo, Ana Maria, Stemke-Hale, Katherine, Hauptmann, Michael, Beijersbergen, Roderick L., Mills, Gordon B., van de Vijver, Marc J., Bernards, René
Published in Cancer cell (01.10.2007)
Published in Cancer cell (01.10.2007)
Get full text
Journal Article
3OComprehensive evaluation of methodology to assess abundance of immune infiltrates in breast cancer
Nederlof, I, de Bortoli, D, Bareche, Y, Hooijer, G K J, Sotiriou, C, van de Vijver, M J, Horlings, H M, Salgado, R, Biganzoli, E, Desmedt, C
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Comprehensive evaluation of methodology to assess abundance of immune infiltrates in breast cancer
Nederlof, I., de Bortoli, D., Bareche, Y., Hooijer, G.K.J., Sotiriou, C., van de Vijver, M.J., Horlings, H.M., Salgado, R., Biganzoli, E., Desmedt, C.
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Abstract P3-06-02: Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer
Nguyen, B, Venet, D, Lambertini, M, Desmedt, C, Salgado, R, Horlings, HM, Rothe, F, Sotiriou, C
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P2-07-04: Prognostic value of residual cancer burden (RCB), neo-bioscore and neoadjuvant response index (NRI) to evaluate response to neoadjuvant trastuzumab-based therapy in HER2-positive breast cancer (BC)
Steenbruggen, TG, van Seijen, M, Janssen, LM, van Ramshorst, MS, van Werkhoven, E, Lips, EH, Vrancken-Peeters, M-JT, Horlings, HM, Wesseling, J, Sonke, GS
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article